Objective:

To explore best practices for the identification, education, support, treatment decisions, and resource management for patients with geographic atrophy (GA).

Key Findings:

• New treatments for GA require frequent office visits for injections.
• Patient motivation for treatment is higher in those with significant vision loss or documented GA progression.
• Team collaboration is essential for effective patient management and education.

Interpretation:

The introduction of novel therapies for GA necessitates a comprehensive approach to patient management, emphasizing education, support, and resource optimization.

Limitations:

• Potential safety concerns associated with new treatments, such as intraocular inflammation and other complications.
• Challenges in managing patient flow and scheduling due to increased treatment demands.

Conclusion:

Adapting office dynamics and fostering a supportive environment can significantly enhance the quality of life for GA patients.